1. Home
  2. SGI vs VTRS Comparison

SGI vs VTRS Comparison

Compare SGI & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGI

Somnigroup International Inc.

HOLD

Current Price

$74.15

Market Cap

16.3B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$16.19

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGI
VTRS
Founded
1846
1961
Country
United States
United States
Employees
19000
30000
Industry
Home Furnishings
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
18.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SGI
VTRS
Price
$74.15
$16.19
Analyst Decision
Strong Buy
Buy
Analyst Count
8
4
Target Price
$97.88
$13.50
AVG Volume (30 Days)
2.5M
9.6M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
0.90%
3.21%
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
N/A
$14,299,900,000.00
Revenue This Year
$7.30
$4.41
Revenue Next Year
$4.99
$1.96
P/E Ratio
$48.98
$108.93
Revenue Growth
N/A
N/A
52 Week Low
$60.39
$8.63
52 Week High
$98.56
$17.53

Technical Indicators

Market Signals
Indicator
SGI
VTRS
Relative Strength Index (RSI) 50.38 50.20
Support Level $72.02 $16.02
Resistance Level $79.25 $16.54
Average True Range (ATR) 2.41 0.43
MACD -0.40 0.02
Stochastic Oscillator 34.24 53.94

Price Performance

Historical Comparison
SGI
VTRS

About SGI Somnigroup International Inc.

Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses Mattress Firm, Tempur Sealy North America and Tempur Sealy International. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: